# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-104497
Filing Date
2024-10-01
Accepted
2024-09-30 20:43:57
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-10-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm2422916d2_ars.pdf | ARS | 667503
| Complete submission text file | 0001104659-24-104497.txt |  | 921023

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-12584 | Film No.: 241340993
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)